Tyme technologies Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Tyme technologies Contact Number

Contact Us Tyme Global Technologies Remote Customer

8 hours ago Tymeglobal.com Show details

212-796-1950TGT delivers customer service like no other company in the business! Our Address. 60 West 66th Street, New York, NY, 10023. Our Phone Number. 212-796-1950. Email Us. [email protected] Contact Hours. 24/7/365, Always On.

Estimated Reading Time: 1 min
Phone: (212) 796-1950
Location: 60 West 66th Street, New York, 10023, NY

Category: Customer Service, Contact SupportShow more

TYME Inc. Contact Us

2 hours ago Tymeinc.com Show details

(212) 461-2315Contact the TYME Team to learn more. TYME Technologies Inc., 1 Pluckemin Way, Suite 103; Bedminster, NJ 07921

Location: 17 State Street, New York, 10004, NY
Phone: (212) 461-2315

Category: Contact SupportShow more

TYME Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

212-461-2315Contact Email [email protected]tymeinc.com. Phone Number +1 212-461-2315. TYME Inc. is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s

Founder: Steven Hoffman

Category: Contact NumberShow more

Tyme Global Technologies Crunchbase Company Profile

4 hours ago Crunchbase.com Show details

212-796-1950Contact Email [email protected] Phone Number +1 212-796-1950 Tyme Global Technologies, a US based, communications and software company focused on the hospitality industry, enhances your customer and guest experience through our innovative products such as remote voice operators, IP based PBX, backup SIP services, and text messaging.

Founded: 2013

Category: Tech SupportShow more

Tyme Technologies Overview, News & Competitors

8 hours ago Zoominfo.com Show details

(212) 461-2315TYME Technologies, Inc. to Host Conference Call and Webcast on Monday, November 8th at 8:30 AM ET BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that the Company will report its …

Employees: 25
Phone: (212) 461-2315
Location: 17 State St, 7th Floor, New York City, 10004

Category: Tech SupportShow more

TYME TECHNOLOGIES, INC. (Form: 8K, Received: 07/13/2020

1 hours ago Content.edgar-online.com Show details

125-20-1919Tyme Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38169 45-3864597 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)

Category: Tech SupportShow more

Steve Hoffman Chairman and Ch.. Tyme Technologies

Just Now Zoominfo.com Show details

View Steve Hoffman's business profile as Chairman and Chief Science Officer at Tyme Technologies. Find contact's direct phone …

Category: Tech SupportShow more

Tyme Technologies, L.L.C. in Meraux, LA Company Info

5 hours ago Bizapedia.com Show details

Tyme Technologies, L.L.C. is a Louisiana Limited-Liability Company filed On April 9, 2001. The company's filing status is listed as Inactive - Action By Secretary Of State and its File Number is 35070804K. The Registered Agent on file for this company is Raymond E. Garofalo, Jr. and is located at 2304 Etienne Dr, Meraux, LA 70075.

Location: LA

Category: Tech SupportShow more

TYME Help Center

8 hours ago Support.tymestyle.com Show details

Articles. What makes the TYME Iron different? Does the TYME Iron work on my hair type? How do I request a return or warranty claim? How long does shipping take? How can I cancel or update my order? TYME eGift Card FAQs.

Category: Contact NumberShow more

TYME Short Interest Tyme Technologies Inc Short

8 hours ago Fintel.io Show details

020-05-202020-05-20 sec.gov - ex-4.1 exhibit 4.1 the number of shares of common stock issuable upon exercise of this warrant may be less than the amounts set forth on the face hereof pursuant to section 1(a) of this warrant. tyme technologies, inc.

Category: Tech SupportShow more

TYME Tyme Technologies Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

TYME Technologies, Inc. (NASDAQ: TYME) (the "Company" or "TYME"), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that the Company will report its second quarter 2022 financial results on Monday, November 8, 2021 at 8:30 AM ET.

Category: Tech SupportShow more

TYME Institutional Ownership Tyme Technologies Inc

8 hours ago Fintel.io Show details

018-07-312018-07-31 sec.gov - Exhibit 10.4 TYME TECHNOLOGIES, INC. 17 State Street – 7th Floor New York, New York 10004 July 30, 2018 Jonathan Eckard Dear Jon: This letter sets forth our amended and restated agreement with respect to your employment (hereinafter “amended letter agreement”) with Tyme Technologies, Inc., a Delaware corporation (the

Category: Tech SupportShow more

Tyme Technologies, Inc. (TYME) Company Profile & Overview

6 hours ago Stockanalysis.com Show details

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma.

Category: Tech SupportShow more

Tyme Technologies, Inc. (TYME) Company Profile & Facts

5 hours ago Finance.yahoo.com Show details

See the company profile for Tyme Technologies, Inc. (TYME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Tech SupportShow more

TYME TECHNOLOGIES, INC. (Form: 8K, Received: 08/03/2020

Just Now Content.edgar-online.com Show details

125-20-2074Tyme Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38169 45-3864597 (Address of principal executive offices, including zip code) (212) 461-2201 (Registrant’s telephone number, including area code) 17 State Street – 7th Floor . Contact: 1-212-461-2315

Category: Tech SupportShow more

TYME Technologies, Inc. to Host Conference Call and

6 hours ago Us.acrofan.com Show details

Company to report its second quarter fiscal 2022 financial resultsBEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that the Company will report its second quarter 2022 financial …

Category: Tech SupportShow more

CONTACT Thyme Technologies

2 hours ago Thymetech.co.za Show details

We would love to hear from you, get in touch with our teams.

Category: Contact Support, Tech SupportShow more

What You Need To Know Before Buying TYME Technologies Inc

3 hours ago Benzinga.com Show details

Step 2: Select your number of shares. The number of shares you buy depends primarily on your budget. You should consider your current position on TYME stock. Review the volatility of the market

Category: Tech SupportShow more

Tyme Global Technologies Virtual Receptionist Tyme Global

7 hours ago Tymeglobal.com Show details

212-796-1950Contact Us Anytime. Contact Tyme Global Technologies for all of your telecommunications needs. Call 212-796-1950 or email us at [email protected] We are available 24/7, all year round. Customer Satisfaction.

Category: Tech SupportShow more

Tyme Technologies LLC in Brookfield, CT Company Info

5 hours ago Bizapedia.com Show details

Tyme Technologies LLC is a Connecticut Domestic Limited-Liability Company filed On January 29, 2008. The company's filing status is listed as Active and its File Number is 0926374. The Registered Agent on file for this company is Michele Meyhoefer and is located at 64 Triangle Street, Danbury, CT 06810.

Location: CT

Category: Tech SupportShow more

TYME Inc. Scientific Solutions Without Compromise

1 hours ago Tymeinc.com Show details

TYME continues to develop a strong pipeline of cancer metabolism-based therapies for advanced cancers. We are focusing on metastatic and hard-to-treat cancers for which current therapies are inadequate. We believe that targeting cancer’s metabolism by disrupting protein synthesis and increasing oxidative stress has advantages over existing

Category: Contact NumberShow more

TYME Technologies (@tyme_inc) Twitter

8 hours ago Twitter.com Show details

The latest tweets from @tyme_inc

Followers: 1.2K

Category: Tech SupportShow more

Tyme Technologies Inc (TYME) Down 1.83% in Premarket Trading

9 hours ago Investorsobserver.com Show details

Tyme Technologies Inc has a Long-Term Technical rank of 13. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 87% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, TYME ranks better than 27% of stocks. Important Dates for Investors in TYME:

Category: Tech SupportShow more

TYME Granted U.S. Patent Claims Covering Use of TYME19 to

4 hours ago Finance.yahoo.com Show details

Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low …

Category: Contact NumberShow more

Jobs with Tyme, Inc. BioSpace

1 hours ago Biospace.com Show details

Tyme Technologies to Present at BIO Digital from June 8-12, 2020. 5/27/2020. Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present a corporate overview for 2020 at BIO Digital from June 8-12.

Category: Contact NumberShow more

TYME Technologies, Inc. to Host Conference Call and

1 hours ago Argus-press.com Show details

BEDMINSTER, N.J.--(BUSINESS WIRE)--Oct 27, 2021--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based

Category: Tech SupportShow more

Tyme Technologies Inc (TYME) has gained 3.09% Monday In

2 hours ago Investorsobserver.com Show details

Tyme Technologies Inc has a Long-Term Technical rank of 18. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 82% of the market scoring higher. In the Biotechnology industry which is number 133 by this metric, TYME ranks better than 43% of stocks. Important Dates for Investors in TYME:

Category: Tech SupportShow more

Current Report Filing (8k)

9 hours ago Ih.advfn.com Show details

Introductory Comment – Use of Terminology. Throughout this Current Report on Form 8-K, the terms “the Company,” “we” and “our” refer to Tyme Technologies, Inc., a Delaware corporation, together with its subsidiaries (“ TYME ”).. Item 2.02. Results of Operations and Financial Condition. On November 8, 2021, TYME released financial information for the …

Category: Contact NumberShow more

Tyme Technologies Inc Company Profile and News

9 hours ago Bloomberg.com Show details

Tyme Technologies Inc. Tyme Technologies, Inc. operates as a a clinical-stage bio-technology company. The Company discovers and develops cancer therapeutics technology for …

Category: Tech SupportShow more

Tyme Technologies Announces Virtual 2020 Annual Meeting of

8 hours ago Businesswire.com Show details

NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that TYME will hold its 2020

Category: Tech SupportShow more

TYME TECHNOLOGIES, INC. Management's Discussion and

5 hours ago Marketscreener.com Show details

The disclosures in this Quarterly Report are complementary to those made in our Annual Report on Form 10-K filed with the SEC on June 10, 2021 (the "2021 10-K"). You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing in this Quarterly Report as …

Category: Tech SupportShow more

TYME 13F Hedge Fund and Asset Management Owners

5 hours ago Whalewisdom.com Show details

646-205-160315. 44 WALL STREET, 12TH FLOOR, NEW YORK, NY 10005. 646-205-1603. TYME is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be effective across a broad range of solid tumors and hematologic cancers, while also maintaining patients’ quality of life through relatively low toxicity

Category: Contact NumberShow more

TYME Granted U.S. Patent Claims Covering Use of TYME19 to

1 hours ago Businesswire.com Show details

TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections. February 03, 2021 08:00 AM Eastern Standard Time. BEDMINSTER, N.J.-- ( BUSINESS WIRE )-- Tyme Technologies

Category: Contact NumberShow more

TYME Technologies, Inc. to Present at Jefferies London

7 hours ago Us.acrofan.com Show details

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business Officer, will present at the Jefferies …

Category: Tech SupportShow more

Statement of Changes in Beneficial Ownership (4)

Just Now Ih.advfn.com Show details

Statement of Changes in Beneficial Ownership (4) October 14 2021 - 05:25PM. Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1 (b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 STATEMENT OF CHANGES IN …

Category: Contact NumberShow more

Tyme Technologies, Inc. (TYME) Stock Price, News, Quote

Just Now Ca.finance.yahoo.com Show details

TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results. BEDMINSTER, N.J., November 08, 2021--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial …

Category: Tech SupportShow more

TYME Granted U.S. Patent Claims Covering Use of TYME19 to

8 hours ago Benzinga.com Show details

TYME-19 is an investigational compound that is not approved in the U.S. for any disease indication. About TYME-19. TYME-19 is an oral synthetic member of the bile acid family that the Company also

Category: Contact NumberShow more

TYME Stock Forecast, Price & News (Tyme Technologies)

6 hours ago Marketbeat.com Show details

Tyme Technologies' stock was trading at $1.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TYME stock has decreased by 24.2% and is now trading at $0.7960. View which stocks have been most impacted by COVID-19.

Category: Tech SupportShow more

Tyme Technologies Price Forecast Naive Prediction TYME

9 hours ago Macroaxis.com Show details

Although open interest is a measure utilized in the options markets, it could be used to forecast Tyme Technologies' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will.Since open interest Tyme Technologies' options reflect these daily shifts, investors could use the patterns of these …

Category: Tech SupportShow more

TYME Stock Price and Chart — NASDAQ:TYME — TradingView

8 hours ago Tradingview.com Show details

Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael

Category: Contact NumberShow more

TYME Stock Price Tyme Technologies Inc. Stock Quote (U.S

8 hours ago Marketwatch.com Show details

Tyme Technologies stock soars on heavy volume after upbeat update to cancer treatment study Jul. 5, 2019 at 9:46 a.m. ET by Tomi Kilgore No Headlines Available

Category: Tech SupportShow more

Steve Hoffman Managing Partner Yamo Pharmaceuticals

Just Now Linkedin.com Show details

1995 - 200914 years. Engineering and industrial solutions in material finishing to improve wear, mecahnical, and chemical properties. Special attention to preformance automotive.

Title: Chairman Of The Board TYME
Location: United States
Connections: 104

Category: Contact NumberShow more

TYME Granted U.S. Patent Claims Covering Use of TYME19 to

1 hours ago Nasdaq.com Show details

Tyme Technologies, Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced that it has received notification that the United States Patent and Trademark

Category: Contact NumberShow more

Tyme Technologies : Announces SM88 Abstract Selected for

7 hours ago Marketscreener.com Show details

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that an abstract highlighting clinical data for TYME's lead candidate, oral SM-88 (racemetyrosine), in patients with metastatic pancreatic cancer, has been selected for poster presentation at the American …

Category: Tech SupportShow more

Tyme Technologies, Inc. (TYME) FORM 8K Current report

9 hours ago Seekingalpha.com Show details

311 45-3864Delaware 333-179311 45-3864597 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)

Category: Tech SupportShow more

Gili Koren V.P. Training Tyme Global Technologies

4 hours ago Apollo.io Show details

Tyme Global Technologies, a US based, communications and software company focused on the hospitality industry, enhances your customer and guest experience through our innovative products such as remote voice operators, IP based PBX, …

Category: Tech SupportShow more

Tyme Announces Issuance of Second Core Platform Patent

5 hours ago Globenewswire.com Show details

Tyme Technologies is developing a novel first-in-class therapy, SM-88, that is designed to use cancer’s unusual metabolism to selectively break down the cellular defenses of tumors, leading to

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What does Tyme technologies do?

Tyme Technologies, Inc. operates as a a clinical-stage bio-technology company. The Company discovers and develops cancer therapeutics technology for the treatment of tumor and prostate cancer. Tyme Technologies serves clients in the State New York. NO.

How do I contact Tyme Global Technologies?

Contact Tyme Global Technologies for all of your telecommunications needs. Call 212-796-1950 or email us at [email protected] We are available 24/7, all year round.

How much is a share of Tyme worth?

One share of TYME stock can currently be purchased for approximately $1.04. How much money does Tyme Technologies make? Tyme Technologies has a market capitalization of $179.10 million.

When is Tyme technologies' next quarterly earnings release?

Tyme Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021. View our earnings forecast for Tyme Technologies. How were Tyme Technologies' earnings last quarter?

Popular Brands

Tsmc
Tesla
Tata
Toyota
Tesco
Tgs
Tui